NO964610L - Foröket biotilgjengelighet av biologisk aktive forbindelser ved binding til polypyrrolkarboksamidonaftalenderivater - Google Patents

Foröket biotilgjengelighet av biologisk aktive forbindelser ved binding til polypyrrolkarboksamidonaftalenderivater

Info

Publication number
NO964610L
NO964610L NO964610A NO964610A NO964610L NO 964610 L NO964610 L NO 964610L NO 964610 A NO964610 A NO 964610A NO 964610 A NO964610 A NO 964610A NO 964610 L NO964610 L NO 964610L
Authority
NO
Norway
Prior art keywords
biologically active
carboxamidone
polypyrrole
binding
active compounds
Prior art date
Application number
NO964610A
Other languages
English (en)
Norwegian (no)
Other versions
NO964610D0 (no
Inventor
Nicola Mongelli
Andrea Lomdardi Borgia
Enrico Pesenti
Giovanni Biasoli
Marina Ciomei
Francesco Angelicci
Original Assignee
Pharmacia & Upjohn Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Spa filed Critical Pharmacia & Upjohn Spa
Publication of NO964610L publication Critical patent/NO964610L/no
Publication of NO964610D0 publication Critical patent/NO964610D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO964610A 1995-03-01 1996-10-31 Foröket biotilgjengelighet av biologisk aktive forbindelser ved binding til polypyrrolkarboksamidonaftalenderivater NO964610D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9504065.5A GB9504065D0 (en) 1995-03-01 1995-03-01 Poly-pyrrolecarboxamidonaphthalenic acid derivatives
PCT/EP1996/000528 WO1996026950A1 (en) 1995-03-01 1996-02-08 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives

Publications (2)

Publication Number Publication Date
NO964610L true NO964610L (no) 1996-10-31
NO964610D0 NO964610D0 (no) 1996-10-31

Family

ID=10770421

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964610A NO964610D0 (no) 1995-03-01 1996-10-31 Foröket biotilgjengelighet av biologisk aktive forbindelser ved binding til polypyrrolkarboksamidonaftalenderivater

Country Status (18)

Country Link
EP (1) EP0758339A1 (es)
JP (1) JPH10504319A (es)
KR (1) KR970702868A (es)
CN (1) CN1148391A (es)
AR (1) AR002280A1 (es)
AU (1) AU696470B2 (es)
CA (1) CA2189358A1 (es)
EA (1) EA000006B1 (es)
FI (1) FI964331A (es)
GB (1) GB9504065D0 (es)
HU (1) HUP9603305A3 (es)
IL (1) IL117193A0 (es)
MX (1) MX9605089A (es)
NO (1) NO964610D0 (es)
NZ (1) NZ302267A (es)
PL (1) PL317094A1 (es)
WO (1) WO1996026950A1 (es)
ZA (1) ZA961636B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4459297A (en) * 1996-09-30 1998-04-24 Bayer Aktiengesellschaft Glycoconjugates from modified camptothecin derivates (20-o-linkage)
DE19640969A1 (de) * 1996-10-04 1998-04-16 Bayer Ag 20-0-verknüpfte Glycokonjugate von Camptothecin
ID23424A (id) * 1997-05-14 2000-04-20 Bayer Ag Glikokonjugat dari 20(s)-kamptotesin
GB9713733D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Poly-branched polycarboxamido compounds
GB9713732D0 (en) * 1997-06-27 1997-09-03 Pharmacia & Upjohn Spa Substituted triazinic compounds
US6485514B1 (en) 1997-12-12 2002-11-26 Supergen, Inc. Local delivery of therapeutic agents
US6288072B1 (en) * 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition
US6350756B1 (en) 2001-01-18 2002-02-26 California Pacific Medical Center Camptothecin derivatives
US6855720B2 (en) 2001-03-01 2005-02-15 California Pacific Medical Center Nitrogen-based camptothecin derivatives
US6403604B1 (en) 2001-03-01 2002-06-11 California Pacific Medical Center Nitrogen-based camptothecin derivatives
EP1401817A4 (en) 2001-06-13 2005-11-02 Genesoft Pharmaceuticals Inc ISOQUINOLINE COMPOUNDS WITH ANTI-INFECTIOUS ACTIVITY
AU2003249641B2 (en) * 2002-05-16 2009-08-20 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
WO2003101998A1 (en) 2002-06-03 2003-12-11 California Pacific Medical Center Nitrogen-based homo-camptothecin derivatives
AU2003258022A1 (en) 2002-08-02 2004-02-23 Genesoft Pharmaceuticals, Inc. Biaryl compounds having anti-infective activity
US7265129B2 (en) 2002-10-25 2007-09-04 Genesoft Pharmaceuticals, Inc. Anti-infective biaryl compounds
EP1587529A4 (en) 2002-12-10 2009-08-12 Oscient Pharmaceuticals Corp ANTIBACTERIAL COMPOUNDS HAVING A PATTERN (CARBOXAMIDE PYRROLE) - (BENZAMIDE) - (IMIDAZOLE CARBOXAMIDE)
PT2264043T (pt) 2005-09-02 2018-01-19 Glycomimetics Inc Inibidores de pan-selectina heterobifuncionais
US7875602B2 (en) 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
WO2009126556A1 (en) 2008-04-08 2009-10-15 Glycomimetics, Inc. Pan-selectin inhibitor with enhanced pharmacokinetic activity
WO2011163572A2 (en) * 2010-06-24 2011-12-29 University Of Kansas Bifunctional conjugate compositions and associated methods
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
PT2794626T (pt) 2011-12-22 2018-01-12 Glycomimetics Inc Compostos de antagonistas de e-selectina
SI2928476T1 (en) 2012-12-07 2018-06-29 Glycomimetics, Inc. COMPONENTS, INSTALLATIONS AND PROCEDURES OF THE APPLICATION OF E-SELECTINE OF ANTAGONISTS FOR THE MOBILIZATION OF HEMATOPOETIC CELLS
HUE045542T2 (hu) 2014-12-03 2019-12-30 Glycomimetics Inc E-szelektinek és CXCR4 kemokin receptorok heterobifunkcionális inhibitorai
CA3009836A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
WO2017151708A1 (en) 2016-03-02 2017-09-08 Glycomimetics, Inc. Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin
EP3497131B1 (en) 2016-08-08 2022-03-09 GlycoMimetics, Inc. Combination of t-cell checkpoint inhibitors with inhibitors of e-selectin or cxcr4, or with heterobifunctional inhibitors of both e-selectin and cxcr4.
KR102653723B1 (ko) 2016-10-07 2024-04-01 글리코미메틱스, 인크. 매우 강력한 다량체성 e-셀렉틴 길항물질
US11197877B2 (en) 2017-03-15 2021-12-14 Glycomimetics. Inc. Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonists
EP3381897A1 (en) 2017-03-27 2018-10-03 Leadiant Biosciences SA Derivatives of the disodium 2,2'-{carbonylbis[imino-3,1-phenylenecarbonylimino(1-methyl-1h-pyrrole-4,2-diyl)carbonylimino]}dinaphthalene-1,5-disulfonate salt and related compounds as heparanase inhibitors for the treatment of cancer
EP3717013A1 (en) 2017-11-30 2020-10-07 GlycoMimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
WO2019133878A1 (en) 2017-12-29 2019-07-04 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
JP7455064B2 (ja) 2018-03-05 2024-03-25 グリコミメティクス, インコーポレイテッド 急性骨髄性白血病および関連状態を処置する方法
WO2020139962A1 (en) 2018-12-27 2020-07-02 Glycomimetics, Inc. Heterobifunctional inhibitors of e-selectin and galectin-3
WO2021118927A1 (en) 2019-12-13 2021-06-17 Insideoutbio, Inc. Methods and compositions for targeted delivery of nucleic acid therapeutics
CN114933569B (zh) * 2022-04-07 2024-07-23 澳门科技大学 鞘脂类化合物、含有鞘脂类化合物的脂质体和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9000644D0 (en) * 1990-01-11 1990-03-14 Erba Carlo Spa New ureido derivatives of poly-4-amino-2-carboxy-1-methyl compounds
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
GB9307948D0 (en) * 1993-04-16 1993-06-02 Erba Carlo Spa Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease
GB9403909D0 (en) * 1994-03-01 1994-04-20 Erba Carlo Spa Ureido derivatives of naphthalenephosphonic acids and process for their preparation

Also Published As

Publication number Publication date
CA2189358A1 (en) 1996-09-06
KR970702868A (ko) 1997-06-10
GB9504065D0 (en) 1995-04-19
ZA961636B (en) 1996-09-06
EP0758339A1 (en) 1997-02-19
NO964610D0 (no) 1996-10-31
FI964331A0 (fi) 1996-10-28
AR002280A1 (es) 1998-03-11
EA000006B1 (ru) 1997-12-30
PL317094A1 (en) 1997-03-17
CN1148391A (zh) 1997-04-23
HUP9603305A2 (en) 1997-08-28
MX9605089A (es) 1997-12-31
EA199600104A1 (ru) 1997-09-30
JPH10504319A (ja) 1998-04-28
IL117193A0 (en) 1996-06-18
AU4869896A (en) 1996-09-18
WO1996026950A1 (en) 1996-09-06
FI964331A (fi) 1996-11-01
NZ302267A (en) 1997-10-24
AU696470B2 (en) 1998-09-10
HUP9603305A3 (en) 1998-01-28

Similar Documents

Publication Publication Date Title
NO964610L (no) Foröket biotilgjengelighet av biologisk aktive forbindelser ved binding til polypyrrolkarboksamidonaftalenderivater
DK0865281T3 (da) Naphthylsubstituerede benzimidazolderivater som antikoagulerende midler
DK0868424T3 (da) 4-Pyrimidinyl- eller 4-pyrazinyl-piperazinyl-phenyloxazolidinonderivater, fremstilling deraf og anvendelse deraf som antibakterielle midler
DK0669935T3 (da) Forbindelser, som er anvendelige som sødemidler, og fremgangsmåde til deres fremstilling
AU5577598A (en) Pyrrolidine derivatives having phospholipase a2 inhibitory activity
NO20016401L (no) Th2 differensieringsinhibitorer
UA66864C2 (uk) Похідні сечовини, фармацевтична композиція і спосіб лікування або профілактики запальних, аутоімунних або респіраторних захворювань
AU7368391A (en) 2,8-dioxabicyclo(3,2,1)octane derivatives and culture of MF5453 for their production and use as antihypercholesterolemics
EP0807630A4 (en) HETEROCYCLIC CONNECTIONS
CA2103590A1 (en) Benzamide derivative
MX9804046A (es) 6-0-metil eritromicina d y proceso para hacerla.
EP0903347A4 (es)
ES2183184T3 (es) Derivados seleccionados del compuesto k-252a.
NO981393L (no) Guanidinoproteasehemmere
AU4163696A (en) Process for the preparation of amidino phenyl pyrrolidine beta -alanine urea analogs
AU1171897A (en) 1-methylcarbapenem derivatives
AU2002246317A1 (en) Novel glucopyranoside, process for isolation thereof, pharmaceutical composition containing same and use thereof
ATE247108T1 (de) Antifungale tetrahydrofurane
NO940018D0 (no) Fremgangsmaate for fremstilling av svovelholdige imidazolderivater
YU3099A (sh) Novi derivati eritromicina, postupak za njihovo dobijanje i njihova primena
MX9703146A (es) Derivados de acido propenoico substituido con heterociclo como antagonistas de nmda.
FI873270A (fi) De-(acetylglukosaminyl)-di(dehydro) -deoxi-teikoplaninderivat.
AU7020996A (en) UCK14 compounds
NO994108L (no) Fremgangsmaate ved fremstilling av 4H-4-okso-kinolizin-3-karboksylsyrederivater
WO2001060832A3 (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof